Allysta
is a biopharmaceutical company that researches and develops peptide therapeutics for the treatment of nonalcoholic steatohepatitis... Read moreAllysta
is a biopharmaceutical company that researches and develops peptide therapeutics for the treatment of nonalcoholic steatohepatitis... Read more
2014
PrivateIndependent Company
News
Nov 08, 2022
Accesswire
Press Release: Allysta : Allysta Pharmaceuticals, Inc. Announces Completion of Enrollment in Phase 2b/3 Clinical Trial (OASIS-1) Evaluating the Efficacy and Safety of ALY688 Ophthalmic Solution in Dry Eye Disease
Jun 22, 2021
Accesswire
Press Release: Allysta : Allysta Pharmaceuticals, Inc. Announces Initiation of Dosing in OASIS-1 Phase 2b/3 Clinical Trial (ALY688-301 Study) Evaluating the Efficacy and Safety of ALY688 Ophthalmic Solution in Dry Eye
Jun 10, 2021
Accesswire
Press Release: Allysta : Allysta Pharmaceuticals, Inc. Announces Start of Phase 1 Clinical Trial of ALY688-SR, a Novel First-in-Class Peptide that Targets Adiponectin Signaling
Dec 16, 2020
Accesswire
Press Release: Allysta : Allysta Pharmaceuticals, Inc. Announces Positive Preclinical Data in a NASH Model Demonstrating its Adiponectin Analogue ALY688 Reduces Liver Fat, Inflammation, and Fibrosis
Dec 01, 2020
Accesswire
Press Release: Allysta : Allysta Pharmaceuticals, Inc. Announces Positive Results from its Phase 1/2a Clinical Trial of ALY688 Ophthalmic Solution in Dry Eye Disease
Jan 08, 2020
FinanzNachrichten
Allysta: Allysta Pharmaceuticals, Inc. Doses First Patient with ALY688 Ophthalmic Solution in Phase 1/2a Dry Eye Study
Looking for similar companies to Allysta?
Allysta News
Allysta Press Releases
Allysta Headquarters
400 Concar Drive
San Mateo, California94402
Driving Directions »Allysta Summary
ABOUT
Overview
Allysta is a biopharmaceutical company that researches and develops peptide therapeutics for the treatment of nonalcoholic steatohepatitis. Allysta was founded in 2014. Allysta's headquarters is located in San Mateo, California, USA 94402. Allysta's ...CEO
Allysta's CEO, Henry Hsu, currently has an approval rating of 90%. Allysta's primary competitors are Madrigal, Metacrine, 89bio and 1 more.Website
allysta.comCompetitors
View 4 Allysta competitors here.Acquisitions
There have been no acquisitions found related to AllystaInvestments
Recent investment data cannot be found related to AllystaFrequently Asked Questions about Allysta
When was Allysta founded?
Allysta was founded in 2014Who is Allysta's CEO?
Allysta's CEO is Henry HsuHow much revenue does Allysta generate?
Allysta generates $ < 1M in revenueHow much funding does Allysta have?
Allysta has historically raised $20M in funding
Where is Allysta's headquarters?
Allysta's headquarters is in San Mateo California, USAHow many employees does Allysta have?
Allysta has 20 employeesWhat sector does Allysta operate in?
Allysta is in Pharmaceuticals, BiotechnologyWho are Allysta's competitors?
Allysta's top competitors are Madrigal, Metacrine, 89bio